Blog - Urogynecology

Posted on February 11, 2020 by Marty Aisenberg

Last April I wrote about the FDA’s decision to ban the use of surgical mesh devices for transvaginal repair of pelvic organ prolapse (“transvaginal mesh” or “pelvic mesh”).  https://www.videntpartners.com/blog/2019/fda-bans-surgical-mesh-transvaginal-repair-pelvic-organ-prolapse.  Of course, because transvaginal mesh was used for that purpose for 14 years (2002-2016), the resulting litigation isn’t over yet.  The most recent case to come to my attention is Kaiser v.

Categories

ACA
FDA
Vident
2024 © Vident Partners.